|
US4013682A
(en)
*
|
1973-08-03 |
1977-03-22 |
Akzona Incorporated |
N-hydroxy-amidine compounds
|
|
NL7315350A
(nl)
*
|
1973-11-09 |
1975-05-13 |
Akzo Nv |
Nieuwe aminoguanidine verbindingen.
|
|
US4101675A
(en)
*
|
1973-11-09 |
1978-07-18 |
Akzona Incorporated |
Novel 2,6-di-substituted phenyl-aminoquanidine containing compositions and methods of using same and pharmaceutical compositions containing the same and therapeutic method
|
|
NL7407469A
(nl)
*
|
1974-06-01 |
1975-12-03 |
Akzo Nv |
Nieuwe amidinohydrazonverbindingen.
|
|
US5312840A
(en)
*
|
1986-07-10 |
1994-05-17 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
|
US5385946A
(en)
*
|
1986-07-10 |
1995-01-31 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Method for treating hypertension with disubstituted granidine compounds
|
|
US5262568A
(en)
*
|
1990-03-02 |
1993-11-16 |
State Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
KR100353486B1
(ko)
|
1990-03-02 |
2003-01-06 |
스테이트 오브 오레곤,액팅 바이 앤드 쓰로우 디 오레곤 스테이트 보드 오브 하이어 에주케이션,액팅포앤드 온 비해프 오브 디 오레곤 헬쓰 사이언시즈 유니버시티 앤드 더 유니버시티 오브 오레곤,유진,오레곤 |
삼치환및사치환된구아니딘류및이를함유하는약제조성물
|
|
US5336689A
(en)
*
|
1990-03-02 |
1994-08-09 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
JPH05508836A
(ja)
*
|
1990-05-25 |
1993-12-09 |
オレゴン州 |
シグマ受容体に対して高い結合性を有する置換グアニジンおよびその使用
|
|
US5741661A
(en)
*
|
1991-02-08 |
1998-04-21 |
Cambridge Neuroscience, Inc. |
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
|
|
US5847006A
(en)
*
|
1991-02-08 |
1998-12-08 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
IE920441A1
(en)
*
|
1991-02-08 |
1992-08-12 |
Cambridge Neuroscience Res |
Substituted guanidines and derivatives thereof as modulators¹of neurotransmitter release and novel methodology for¹identifying neurotransmitter release blockers
|
|
KR20030097618A
(ko)
*
|
1993-05-27 |
2003-12-31 |
캠브리지 뉴로사이언스, 인코포레이티드 |
치료용 치환 구아니딘류
|
|
CA2177081A1
(fr)
*
|
1993-11-23 |
1995-06-01 |
Graham J. Durant |
Guanidines substituees a usage therapeutique
|
|
AU1867095A
(en)
*
|
1994-01-10 |
1995-08-01 |
Technion Research & Development Foundation Ltd. |
1-aminoindan derivatives and compositions thereof
|
|
US5914349A
(en)
|
1994-01-10 |
1999-06-22 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
US7351743B1
(en)
|
1994-02-03 |
2008-04-01 |
Wyeth |
Therapeutic guanidines
|
|
US6143791A
(en)
*
|
1994-02-03 |
2000-11-07 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
US6787569B1
(en)
|
1994-02-03 |
2004-09-07 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
ZA95878B
(en)
|
1994-02-03 |
1996-01-16 |
Cambridge Neuroscience Inc |
Therapeutic guanidines
|
|
US6025355A
(en)
|
1997-05-19 |
2000-02-15 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
|
US6242198B1
(en)
|
1996-07-25 |
2001-06-05 |
Cambridge Neuroscience, Inc. |
Methods of treatment of eye trauma and disorders
|
|
US6756389B2
(en)
|
1996-08-09 |
2004-06-29 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
|
EP0966435B1
(fr)
|
1996-12-18 |
2005-04-06 |
Teva Pharmaceutical Industries, Ltd. |
Derives d'aminoindan
|
|
US6737547B1
(en)
|
1998-12-31 |
2004-05-18 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using N-acyl-1H-aminoindenes
|
|
US20040010038A1
(en)
*
|
2002-02-27 |
2004-01-15 |
Eran Blaugrund |
Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
|
|
EP1956904B1
(fr)
*
|
2005-12-09 |
2017-04-12 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Ladostigil a faible dose pour le traitement du déficit cognitif léger
|
|
US20070135518A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Marta Weinstock-Rosin |
Use of low-dose ladostigil for neuroprotection
|
|
TW200744576A
(en)
*
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|